Services

Explore Our Products

Active Pharmaceutical Ingredients

Iopamidol

CAS no.:

60166-93-0

Iopamidol is a low-osmolar, non-ionic contrast medium used for intravascular and body cavity radiographic procedures. It provides clear imaging and minimizes patient discomfort.

Iohexol

CAS no.:

66108-95-0

Iohexol is a non-ionic, water-soluble radiographic contrast agent. It is widely used in diagnostic imaging procedures such as CT scans, angiography, and urography. It offers excellent image enhancement with a favorable safety profile.

Iodixanol

CAS no.:

92339-11-2

Iodixanol is an iso-osmolar, non-ionic dimeric contrast agent under development. It is designed for safe and effective use in various radiographic diagnostic applications.

Iopromide

CAS no.:

73334-07-3

Iopromide is a non-ionic contrast agent used in diagnostic radiology. It is under development to support enhanced imaging in cardiovascular and CT diagnostic procedures.

Ioversol

CAS no.:

87771-40-2

Ioversol is a low-osmolar, non-ionic contrast agent under development for intravenous use. It is being optimized for high image quality and excellent patient tolerability.

Contrast Media Intermediates

5-Amino-2,4,6-Triiodoisophthalic Acid

CAS no.:

35453-19-1

Used as an intermediate for iohexol and iopamidol, this compound is essential for synthesizing high-purity contrast media with reliable performance.

5-Amino-2,4,6-Triiodoisophthaloyl Acid Dichloride

CAS no.:

37441-29-5

This dichloride derivative is utilized in the formulation of contrast agents, enhancing molecular reactivity and structural integration.

5-Acetamido-2,4,6-Triiodoisophthaloyl Dichloride

CAS no.:

31122-75-5

This compound serves as a core intermediate in contrast media manufacturing, offering improved solubility and processing efficiency.

5-(Acetamido)-N,N′-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo-1,3-Benzenedicarboxamide

CAS no.:

31127-80-7

A vital building block in contrast agent synthesis, enabling non-ionic, low-osmolality features for safe diagnostic use.

5-Amino-N,N′-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo-1,3-Benzenedicarboxamide

CAS no.:

76801-93-9

An important intermediate designed for the development of advanced iodinated contrast media offering high patient tolerability.

Explore our full product list, technical specifications, and manufacturing capabilities in detail.

The brochure includes comprehensive information on Active Pharmaceutical Ingredients (APIs), Contrast Media Intermediates, and facility certifications to help you evaluate our offerings with clarity.

Iohexol

CAS no.:

66108-95-0

Iohexol is a non-ionic, water-soluble radiographic contrast agent. It is widely used in diagnostic imaging procedures such as CT scans, angiography, and urography. It offers excellent image enhancement with a favorable safety profile.

Iopamidol

CAS no.:

60166-93-0

Iopamidol is a low-osmolar, non-ionic contrast medium used for intravascular and body cavity radiographic procedures. It provides clear imaging and minimizes patient discomfort.

Iodixanol

CAS no.:

92339-11-2

Iodixanol is an iso-osmolar, non-ionic dimeric contrast agent under development. It is designed for safe and effective use in various radiographic diagnostic applications.

Iopromide

CAS no.:

73334-07-3

Iopromide is a non-ionic contrast agent used in diagnostic radiology. It is under development to support enhanced imaging in cardiovascular and CT diagnostic procedures.

Ioversol

CAS no.:

87771-40-2

Ioversol is a low-osmolar, non-ionic contrast agent under development for intravenous use. It is being optimized for high image quality and excellent patient tolerability.

5-Amino-2,4,6-Triiodoisophthalic Acid

CAS no.:

35453-19-1

Used as an intermediate for iohexol and iopamidol, this compound is essential for synthesizing high-purity contrast media with reliable performance.

5-Amino-2,4,6-Triiodoisophthaloyl Acid Dichloride

CAS no.:

37441-29-5

This dichloride derivative is utilized in the formulation of contrast agents, enhancing molecular reactivity and structural integration.

5-Acetamido-2,4,6-Triiodoisophthaloyl Dichloride

CAS no.:

31122-75-5

This compound serves as a core intermediate in contrast media manufacturing, offering improved solubility and processing efficiency.

5-(Acetamido)-N,N′-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo-1,3-Benzenedicarboxamide

CAS no.:

31127-80-7

A vital building block in contrast agent synthesis, enabling non-ionic, low-osmolality features for safe diagnostic use.

5-Amino-N,N′-Bis(2,3-Dihydroxypropyl)-2,4,6-Triiodo-1,3-Benzenedicarboxamide

CAS no.:

76801-93-9

An important intermediate designed for the development of advanced iodinated contrast media offering high patient tolerability.

Explore our full product list, technical specifications, and manufacturing capabilities in detail.

The brochure includes comprehensive information on Active Pharmaceutical Ingredients (APIs), Contrast Media Intermediates, and facility certifications to help you evaluate our offerings with clarity.

Add Your Heading Text Here

Services at a Glance

Drug Product Development

Formulation design, process optimization, and clinical trial material manufacturing.

Analytical Method Development

Robust analytical testing protocols for quality, stability, and compliance.

Intellectual Property Management

Strategies for patent protection, tech transfer, and freedom-to-operate analysis.

API Synthesis – R&D to Commercial

Comprehensive development and scalable production of Active Pharmaceutical Ingredients.

Portfolio Generation

Support in identifying, evaluating, and expanding your product pipeline.

Regulatory Submission Support

Preparation of global regulatory dossiers and lifecycle documentation.

Please enter your email to download the brochure:​